NEUTREXIN
Dead / Cancelled — Cancelled — Section 8 (as of 03 Apr 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74335524
- Registration number
- 1865146
- Mark type
- Word mark
- Filed
- 30 Nov 1992
- Published for opposition
- 17 Aug 1993
- Registered
- 29 Nov 1994
- Next maintenance due
- 29 Nov 2004
- Attorney of record
- Wm. Charles Saunders
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparation for the treatment of cancer, psoriasis, arthritis, auto-immune diseases and warts (condylomata) and for the treatment and/or prophalaxis administration to prevent or treat pneumocystis carinii pneumonia, toxoplasmosis, and cryptosporidium
Owner
- MEDIMMUNE, LLC, GAITHERSBURG, MD
- MEDIMMUNE ONCOLOGY, INC., GAITHERSBURG, MD, US
- U.S. BIOSCIENCE, INC., West Conshohocken, PA, US
- U.S. BIOSCIENCE, INC., West Conshohocken, PA, US
- U.S. BIOSCIENCE, INC., West Conshohocken, PA, US
Prosecution history
- 03 Apr 2020 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 06 Aug 2008 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Mar 2008 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2008 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jul 2007 — CASE FILE IN TICRS
- 01 Sept 2006 — REVIEW OF CORRESPONDENCE COMPLETE
- 21 Aug 2006 — PAPER RECEIVED
- 18 Jan 2005 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 18 Jan 2005 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Nov 2004 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 23 Nov 2004 — TEAS SECTION 8 & 9 RECEIVED
- 10 Mar 2001 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Nov 2000 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 29 Nov 1994 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 1994 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED